ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

ClinicalTrials.gov ID: NCT00760916

Public ClinicalTrials.gov record NCT00760916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 7:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

FREEDOM DR: An International, Multi-Center, 12-Week, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study Followed by a 12-Week Open-Label Extension Study to Assess the Efficacy, Safety, and Dose Response of UT-15C SR in Subjects With Pulmonary Hypertension

Study identification

NCT ID
NCT00760916
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
United Therapeutics
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Placebo Drug
  • UT-15C 0.25 mg Drug
  • UT-15C 1 mg Drug
  • UT-15C 5 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2008
Primary completion
Dec 31, 2008
Completion
Dec 31, 2008
Last update posted
Jan 29, 2013

2008 – 2009

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama 35294
West Los Angeles VA Healthcare Center Los Angeles California 90073
UC Davis Medical Center Sacramento California 95817
Stanford University Stanford California 94305
Pulmonary Hypertension Clinic Aurora Colorado 80045
University of Iowa Health Care Iowa City Iowa 52242
Kansas University Medical Center Kansas City Kansas 66160
Maine Medical Center Portland Maine 04102
Tufts Medical Center Boston Massachusetts 02111
Massachusetts General Hospital Boston Massachusetts 02114
University of Minnesota Minneapolis Minnesota 55455
Mayo Clinic Rochester Minnesota 55902
Washington University Hospital St Louis Missouri 63110
Weill Cornell Medical Center New York New York 10021
Columbia Presbyterian Medical Center New York New York 10032
Mary M Parkes Center for Asthma, Allergy and Pulmonary Care - University of Rochester Rochester New York 14643
Duke University Medical Center Durham North Carolina 27710
University Hospitals of Cleveland Cleveland Ohio 44106
The Cleveland Clinic Foundation Cleveland Ohio 44195
Ohio State University Columbus Ohio 43210
Lagacy Clinic Northwest Portland Oregon 97210
Allegheny General Hospital Pittsburgh Pennsylvania 15212
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
University of Texas Southwestern Dallas Texas 75235
Intermountain Medical Center Murray Utah 84157-7000
Inova Fairfax Hospital Falls Church Virginia 22042

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00760916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2013 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00760916 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →